Research on the frailty status and adverse outcomes of elderly patients with multimorbidity.
Adverse outcomes
Chronic diseases
Elderly
Frailty
Multimorbidity
Risk factors
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
06 07 2022
06 07 2022
Historique:
received:
26
11
2021
accepted:
02
06
2022
entrez:
5
7
2022
pubmed:
6
7
2022
medline:
8
7
2022
Statut:
epublish
Résumé
As patients age, the frailty of those with multimorbidity increases, often resulting in adverse health outcomes. The current study investigated the frailty status and the factors which influence it in elderly patients with multimorbidity in Chinese hospitals. The relationship between the frailty of patients with multimorbidity and adverse outcomes was explored. The current prospective cohort study investigated inpatients in the internal medicine department of 5 tertiary hospitals in Sichuan Province, China. A total of 3836 elderly patients with multimorbidity were enrolled. Frailty was assessed using the FRAIL scale and adverse outcome events occurring during hospitalization were tracked. Descriptive statistics and logistic regressions were used for data analysis. The prevalence of frailty was 27.2% and of pre-frailty, 58.9%. Logistic regression analysis showed that increasing age, low BMI, low education level, lack of exercise, multiple types of medications and multiple numbers of chronic diseases were the main risk factors for frailty in elderly patients with multimorbidity (OR values: 1.020, 1.469, 2.350, 2.836, 1.156 and 1.308, respectively). The incidence of adverse outcomes was 13.9% among the cohort with the most common being deep vein thrombosis (42.4%), followed by pressure injury (38.8%). Regression analysis showed a significant correlation of frailty with adverse outcome (OR: 1.496; p < 0.01). The prevalence of frailty and pre-frailty in hospitalized elderly patients with multimorbidity was high. Increasing age, low BMI, low education level, lack of exercise, multiple types of medications and multiple numbers of chronic diseases were factors which influenced frailty and frailty was an important factor in the occurrence of adverse outcomes. The most common adverse outcome of elderly multimorbidity patients during hospitalization was deep vein thrombosis.
Sections du résumé
BACKGROUND
As patients age, the frailty of those with multimorbidity increases, often resulting in adverse health outcomes. The current study investigated the frailty status and the factors which influence it in elderly patients with multimorbidity in Chinese hospitals. The relationship between the frailty of patients with multimorbidity and adverse outcomes was explored.
METHODS
The current prospective cohort study investigated inpatients in the internal medicine department of 5 tertiary hospitals in Sichuan Province, China. A total of 3836 elderly patients with multimorbidity were enrolled. Frailty was assessed using the FRAIL scale and adverse outcome events occurring during hospitalization were tracked. Descriptive statistics and logistic regressions were used for data analysis.
RESULTS
The prevalence of frailty was 27.2% and of pre-frailty, 58.9%. Logistic regression analysis showed that increasing age, low BMI, low education level, lack of exercise, multiple types of medications and multiple numbers of chronic diseases were the main risk factors for frailty in elderly patients with multimorbidity (OR values: 1.020, 1.469, 2.350, 2.836, 1.156 and 1.308, respectively). The incidence of adverse outcomes was 13.9% among the cohort with the most common being deep vein thrombosis (42.4%), followed by pressure injury (38.8%). Regression analysis showed a significant correlation of frailty with adverse outcome (OR: 1.496; p < 0.01).
CONCLUSIONS
The prevalence of frailty and pre-frailty in hospitalized elderly patients with multimorbidity was high. Increasing age, low BMI, low education level, lack of exercise, multiple types of medications and multiple numbers of chronic diseases were factors which influenced frailty and frailty was an important factor in the occurrence of adverse outcomes. The most common adverse outcome of elderly multimorbidity patients during hospitalization was deep vein thrombosis.
Identifiants
pubmed: 35790904
doi: 10.1186/s12877-022-03194-1
pii: 10.1186/s12877-022-03194-1
pmc: PMC9258158
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
560Informations de copyright
© 2022. The Author(s).
Références
Clin Interv Aging. 2018 Oct 04;13:1899-1905
pubmed: 30323576
J Korean Med Sci. 2020 Jan 20;35(3):e16
pubmed: 31950775
Br J Clin Pharmacol. 2018 Jul;84(7):1432-1444
pubmed: 29575094
BMC Geriatr. 2021 Jul 19;21(1):432
pubmed: 34281523
Rev Invest Clin. 2016 Mar-Apr;68(2):59-67
pubmed: 27103041
J Am Geriatr Soc. 2004 Oct;52(10):1719-23
pubmed: 15450051
Qual Life Res. 2020 Dec;29(12):3233-3241
pubmed: 32564292
J Nutr Health Aging. 2016;20(8):860-869
pubmed: 27709236
J Nutr Health Aging. 2014 Apr;18(4):429-36
pubmed: 24676326
J Gerontol A Biol Sci Med Sci. 2019 Apr 23;74(5):659-666
pubmed: 29726918
JACC Heart Fail. 2019 Apr;7(4):291-302
pubmed: 30738977
BMC Med. 2015 Aug 03;13:178
pubmed: 26239481
Eur J Cardiovasc Nurs. 2021 Nov 28;20(8):736-744
pubmed: 34160024
Geriatr Gerontol Int. 2015 Jan;15(1):1-10
pubmed: 25163532
J Gerontol A Biol Sci Med Sci. 2017 Oct 01;72(10):1417-1423
pubmed: 28003375
BMC Geriatr. 2021 Jul 30;21(1):447
pubmed: 34330211
BMC Health Serv Res. 2016 Mar 01;16:77
pubmed: 26926525
J Am Med Dir Assoc. 2016 Dec 1;17(12):1163.e1-1163.e17
pubmed: 27886869
J Am Coll Surg. 2021 Dec;233(6):764-775.e1
pubmed: 34438081
BMC Geriatr. 2019 Feb 27;19(1):53
pubmed: 30813907
Age Ageing. 2014 Jul;43(4):515-21
pubmed: 24334709
Lancet Healthy Longev. 2020 Dec;1(3):e106-e116
pubmed: 33313578
BMC Psychiatry. 2020 Dec 1;20(1):573
pubmed: 33261579
Geriatr Gerontol Int. 2018 Dec;18(12):1609-1613
pubmed: 30264424
Pharmacoepidemiol Drug Saf. 2011 May;20(5):514-22
pubmed: 21308855
J Am Med Dir Assoc. 2008 Feb;9(2):71-2
pubmed: 18261696
J Am Geriatr Soc. 2012 Feb;60(2):401
pubmed: 22332700
J Am Med Dir Assoc. 2016 Mar 1;17(3):188-92
pubmed: 26805753
J Am Geriatr Soc. 2005 Aug;53(8):1321-30
pubmed: 16078957
Clin Interv Aging. 2010 Sep 07;5:259-70
pubmed: 20852673
J Am Geriatr Soc. 2010 Apr;58(4):681-7
pubmed: 20345864
Geriatr Nurs. 2021 Jul-Aug;42(4):943-947
pubmed: 34130126
Ann Geriatr Med Res. 2019 Sep;23(3):95-97
pubmed: 32743296
Am J Med. 2012 Jan;125(1):79-86
pubmed: 22195532
Geriatr Nurs. 2020 Mar - Apr;41(2):69-74
pubmed: 30765177
Chest. 2018 Jul;154(1):21-40
pubmed: 29477493
J Nutr Health Aging. 2008 Jan;12(1):29-37
pubmed: 18165842
Mech Ageing Dev. 2020 Dec;192:111384
pubmed: 33080280
Clin Geriatr Med. 2018 Feb;34(1):25-38
pubmed: 29129215